• EORTC ATOM trial
    Categories: ,

    EORTC and Immunocore announce enrolment of first patient onto the only active Phase 3 adjuvant trial in uveal melanoma

    11 Dec 2024

  • ESMO congress 2024
    Categories: , , , , ,

    New results and forthcoming EORTC trials in prostate cancer, melanoma, head and neck, lung, rare, and breast cancers presented at ESMO 2024

    17 Sep 2024

  • EORTC ATOM trial
    Categories: ,

    EORTC and Immunocore are collaborating to launch the ATOM clinical trial of tebentafusp in Adjuvant Uveal Melanoma

    7 Nov 2023

  • New EORTC publications in NEJM and the Lancet Oncology
    Categories: , ,

    Results of two EORTC studies have been published in NEJM and the Lancet Oncology

    21 Sep 2022

  • EORTC Patient recruitment Metastatic Melanoma
    Categories: ,

    EORTC Completes Patient Recruitment to Study of Treatment for unresectable or metastatic melanoma

    5 Aug 2022

  • Dr Martin Charles Mihm
    Categories: ,

    In Memoriam: Dr Martin Charles Mihm

    27 Jul 2022

  • Melanoma
    Categories: ,

    Pierre Fabre and EORTC open a large Phase III clinical study in the adjuvant setting of stage IIB-C melanoma

    24 May 2022

  • Melanoma
    Categories: , ,

    PRESS RELEASE: European Organisation for Research and Treatment of Cancer (EORTC) and Pierre Fabre Partner to Address Treatment Gap for Stage 2 Melanoma Patients

    29 Jun 2021